KIRBY CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that KIRBY CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $489.76M | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | $496.57M | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | $541.16M | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | $643.93M | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $655.93M | Feb 23, 2021 |
| FY2020 | Sep 30, 2019 | $666.81M | Feb 23, 2021 |
| FY2020 | Jun 30, 2019 | $771.04M | Feb 23, 2021 |
| FY2020 | Mar 31, 2019 | $744.62M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $721.49M | Feb 24, 2020 |
| FY2019 | Sep 30, 2018 | $704.85M | Feb 24, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.36B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.27B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $3.09B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $2.78B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $2.25B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $2.17B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $2.84B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $2.97B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $2.21B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $1.77B | Feb 26, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $354.57M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $286.71M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $222.94M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $122.29M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | ($246.95M) | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $22.20M | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | $27.49M | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | $25.00M | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | ($347.24M) | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $2.78M | Feb 23, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $496.28M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $399.10M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $335.09M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $192.89M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | ($258.13M) | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $24.77M | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | $29.91M | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | $34.25M | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | ($509.70M) | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $16.18M | Feb 23, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $356.31M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $337.10M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $335.21M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $302.69M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $266.91M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $258.27M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $277.39M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $304.40M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $220.45M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $174.86M | Feb 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $670.20M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $756.49M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $540.23M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $294.13M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $321.58M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $444.94M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $511.81M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $347.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $353.38M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $415.79M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.01B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $5.85B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $5.72B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $5.55B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $5.40B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $5.92B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $6.08B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $5.87B | Feb 24, 2020 |
| FY2019 | Dec 31, 2017 | $5.13B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $4.29B | Feb 26, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.38B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.35B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $3.19B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $3.04B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.89B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $3.08B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $3.37B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $3.21B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $3.11B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $2.41B | Feb 26, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $438.75M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $438.75M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $438.75M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $438.75M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $438.75M | Feb 21, 2023 |
| FY2022 | Dec 31, 2020 | $657.80M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $953.83M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $953.83M | Feb 23, 2021 |
| FY2018 | Feb 14, 2018 | $4.66M | Feb 26, 2019 |
| FY2020 | Dec 31, 2017 | $935.14M | Feb 23, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.33B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.98B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $2.69B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $2.47B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.35B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $2.59B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $2.87B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $2.72B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $2.65B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $2.34B | Feb 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.78M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $74.44M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $32.58M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $80.58M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $34.81M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $80.34M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $24.74M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $7.80M | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $20.10M | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $5.63M | Feb 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $919.28M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $874.95M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $1.02B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $1.08B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.16B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.47B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.37B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $1.41B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $992.41M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $722.80M | Feb 26, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | (4) | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | (5) | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 23, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | (4) | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | (5) | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 23, 2021 |